This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Phase 3b Study of Participant Experience on Povetacicept Administered Via Autoinjector as Compared to Sibeprenlimab Administered Via Prefilled Syringe | MicrobiomeTrials
← Back to trials NCT07890909
A Phase 3b Study of Participant Experience on Povetacicept Administered Via Autoinjector as Compared to Sibeprenlimab Administered Via Prefilled Syringe Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-10-23Est. Completion: 2027-12-12
Enrollment target: 40 participantsOther microbiome trials you might be interested in Hairy Cell Leukemia (HCL) Chronic Lymphocytic Leukemia (CLL) Non-Hodgkins Lymphoma (NHL) Cutaneous T Cell Lymphoma (CTCL) Adult T Cell Lymphoma (ATL)
Background:
\- Researchers who are studying hairy cell leukemia, and how the disease compares with other disorders, are…
Bethesda, United States
Hereditary Leiomyomatosis and Renal Cell Carcinoma Papillary Renal Cell Carcinoma Renal Cell Carcinoma Sporadic Papillary Renal Cell Carcinoma
Stage III Renal Cell Cancer AJCC v8
Stage IV Renal Cell Cancer AJCC v8
This phase II trial studies the effects of combination therapy with bevacizumab, erlotinib, and atezolizumab in treating…
La Jolla, United States Est. completion Dec 31, 2027
Bladder Adenocarcinoma Bladder Clear Cell Adenocarcinoma Bladder Mixed Adenocarcinoma Bladder Neuroendocrine Carcinoma Bladder Small Cell Neuroendocrine Carcinoma Bladder Squamous Cell Carcinoma Chromophobe Renal Cell Carcinoma Collecting Duct Carcinoma Invasive Bladder Giant Cell Urothelial Carcinoma Invasive Bladder Lymphoepithelioma-Like Carcinoma Invasive Bladder Nested Urothelial Carcinoma Invasive Bladder Plasmacytoid Urothelial Carcinoma Invasive Bladder Sarcomatoid Urothelial Carcinoma Invasive Bladder Urothelial Carcinoma Kidney Medullary Carcinoma Large Cell Neuroendocrine Carcinoma Malignant Testicular Leydig Cell Tumor Malignant Testicular Sertoli Cell Tumor Metastatic Bladder Carcinoma Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma Metastatic Bladder Giant Cell Urothelial Carcinoma Metastatic Bladder Large Cell Neuroendocrine Carcinoma Metastatic Bladder Lipid-Rich Urothelial Carcinoma Metastatic Bladder Micropapillary Urothelial Carcinoma Metastatic Bladder Plasmacytoid Urothelial Carcinoma Metastatic Bladder Sarcomatoid Urothelial Carcinoma Metastatic Bladder Small Cell Neuroendocrine Carcinoma Metastatic Bladder Squamous Cell Carcinoma Metastatic Chromophobe Renal Cell Carcinoma Metastatic Kidney Medullary Carcinoma Metastatic Malignant Genitourinary System Neoplasm Metastatic Papillary Renal Cell Carcinoma Metastatic Penile Carcinoma Metastatic Prostate Small Cell Neuroendocrine Carcinoma Metastatic Sarcomatoid Renal Cell Carcinoma Metastatic Urethral Carcinoma Papillary Renal Cell Carcinoma Sarcomatoid Renal Cell Carcinoma Stage IV Bladder Cancer AJCC v8 Stage IV Penile Cancer AJCC v8 Stage IV Renal Cell Cancer AJCC v8 Stage IV Urethral Cancer AJCC v8 Stage IVB Prostate Cancer AJCC v8 Urachal Adenocarcinoma Urethral Clear Cell Adenocarcinoma
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patient…
Birmingham, United States Est. completion Feb 28, 2027